If You’re Going to JPM, Make it Count.

Breaking Bad Biotech: Practical Advice for Highly Effective Biotech Organizations

Expert insights from Gregg Beloff, Co-Founder and Managing Director of Danforth Health.

If you’ve ever been to the JP Morgan Healthcare Conference, you know it’s less a conference and more a Jungleland – a place where the hopeful and the hardened all show up looking for a breakthrough. The energy is electric, the pace is relentless, and every conversation feels like it could change your company’s trajectory.

But from a CFO’s chair, it’s also something else: an enormous investment. Flights, hotels, receptions, prep work, opportunity cost — the tab adds up fast. If you’ve decided to attend, you must make the investment count.

JPM can be one of the highest-ROI weeks of your year or an expensive blur that drains both capital and focus. The difference lies in your purpose and your planning.

Treat JPM like a strategic investment

Think of JPM as an asset class in your annual operating plan. Before spending a dollar or booking a meeting, define what success looks like in measurable terms.

Start by defining your objectives: are you raising capital, building partnerships, or increasing visibility ahead of a milestone? Each goal requires a different playbook and different KPIs. For example:

  • Investor ROI: How many qualified, decision-making investors will you meet?
  • Partnership traction: Which BD conversations could realistically lead to follow-up diligence?
  • Visibility return: Which events or moments get your story in front of the right audiences?

Just like any investment, JPM needs a thesis and a disciplined approach to executing it.

Focus on Yield, Not Volume

It’s easy to fall into the JPM trap of equating busy with productive. Back-to-back meetings look impressive on paper, but not all of them will actually move the needle.

The best outcomes derive from fewer, more strategic conversations that align with your financing or partnering objectives.

  • Vet every meeting: Is this a potential investor, or an information-gathering analyst?
  • Confirm who’s actually attending: decision-maker or screener?
  • Leave room for recalibration and reflection: time is capital, too.

The week’s real winners are rarely the busiest people in the lobby. They’re the ones whose calendars were curated with purpose.

Manage the Signal-to-Noise Ratio

JPM week is chaos: receptions stacked on panels stacked on hallway introductions. Ask yourself:

  • Which events actually align with your company’s capital or BD strategy?
  • Where will your CEO or CBO’s time have the greatest multiplier effect?
  • What can wait for quieter weeks, when inboxes and attention spans have cleared?

Think portfolio theory: not every opportunity deserves investment.

Make every dollar work harder

Treat JPM the way you’d approach any capital-intensive project — with discipline and intent.

  • Craft a crisp narrative: Tie your science to your strategy and your strategy to value creation. Investors should understand your story in two minutes flat.
  • Pre-plan your follow-ups: Don’t just “circle back.” Assign accountability for post-conference momentum.
  • Invest in presence wisely: Sometimes being seen in the right room creates more value than being everywhere at once.

Efficiency isn’t about doing less. It’s about ensuring every dollar and every hour generates tangible returns.

Close the loop

After JPM, debrief like you would after closing a financing round.

  • What relationships advanced your fundraising or partnership goals?
  • What intel will shape your capital or communications strategy?
  • Did the outcomes justify the spend?
  • What are the follow-ups/next steps, and who is accountable?

Treating JPM as a measurable investment — rather than an annual ritual — is how you turn noise into signal and activity into results.

The Bottom Line

In biotech, every decision is an investment — of time, attention, and capital. Treat JPM with the same financial discipline and focus you’d apply to any major investment. In a place where everyone’s chasing opportunity, the companies that win are the ones that plan, measure, and execute with purpose and intent.

Learn more about Danforth Health and connect with our expert team.